PortfoliosLab logo
HUTCHMED China Ltd (0013.HK)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

Highlights

Market Cap

HK$19.48B

PE Ratio

72.58

Year Range

HK$18.36 - HK$35.90

Target Price

HK$38.96

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Performance

Performance Chart


Loading data...

Returns By Period

HUTCHMED China Ltd (0013.HK) returned 0.45% year-to-date (YTD) and -35.06% over the past 12 months.


0013.HK

YTD

0.45%

1M

7.40%

6M

-20.63%

1Y

-35.06%

5Y*

N/A

10Y*

N/A

^GSPC (Benchmark)

YTD

-3.77%

1M

7.44%

6M

-5.60%

1Y

8.37%

5Y*

14.12%

10Y*

10.46%

*Annualized

Monthly Returns

The table below presents the monthly returns of 0013.HK, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2025-6.70%23.21%-7.38%-2.73%-3.02%0.45%
2024-31.22%22.59%10.54%13.08%-2.64%-6.62%10.00%-8.26%16.04%-11.80%-6.69%-15.47%-21.95%
202320.00%-10.24%-20.12%16.46%-21.00%-2.95%24.73%4.78%10.58%17.82%-3.82%-4.97%19.58%
2022-28.04%5.27%-29.92%-14.62%-34.71%15.26%2.59%-1.71%-32.21%-0.15%62.50%11.89%-57.67%
202117.08%-17.00%-2.73%-18.77%20.95%1.25%-5.97%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of 0013.HK is 26, indicating average performance compared to other stocks on our website. Here’s a breakdown of how it compares using common performance measures.


The Risk-Adjusted Performance Rank of 0013.HK is 2626
Overall Rank
The Sharpe Ratio Rank of 0013.HK is 1919
Sharpe Ratio Rank
The Sortino Ratio Rank of 0013.HK is 2727
Sortino Ratio Rank
The Omega Ratio Rank of 0013.HK is 2727
Omega Ratio Rank
The Calmar Ratio Rank of 0013.HK is 3030
Calmar Ratio Rank
The Martin Ratio Rank of 0013.HK is 2525
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for HUTCHMED China Ltd (0013.HK) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


The Sharpe ratio helps investors understand how much return they're getting for the level of risk taken. A higher Sharpe ratio indicates better risk-adjusted performance, meaning more reward for each unit of risk.

HUTCHMED China Ltd Sharpe ratios as of May 11, 2025 (values are recalculated daily):

  • 1-Year: -0.60
  • All Time: -0.37

These values reflect how efficiently the investment has delivered returns relative to its volatility over different time periods. All figures are annualized and based on daily total returns (including price changes and dividends).

The chart below shows the rolling Sharpe ratio of HUTCHMED China Ltd compared to the selected benchmark. This view highlights how the investment's risk-adjusted performance has changed over time. For deeper analysis or to customize the calculation, use the Sharpe ratio tool.


Loading data...

Dividends

Dividend History


HUTCHMED China Ltd doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading data...

Worst Drawdowns

The table below displays the maximum drawdowns of the HUTCHMED China Ltd. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the HUTCHMED China Ltd was 84.85%, occurring on Oct 24, 2022. The portfolio has not yet recovered.

The current HUTCHMED China Ltd drawdown is 71.01%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-84.85%Jul 30, 2021305Oct 24, 2022
-15.14%Jul 23, 20213Jul 27, 20212Jul 29, 20215
-13.73%Jul 5, 20213Jul 7, 202110Jul 21, 202113

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading data...

Financials

Financial Performance

The chart below illustrates the trends in the financial health of HUTCHMED China Ltd over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.


Annual
Quarterly

0.0

Valuation

The Valuation section provides an overview of how HUTCHMED China Ltd is priced in the market compared to other companies in the Drug Manufacturers - Specialty & Generic industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PE Ratio

The chart displays the Price-to-Earnings (P/E) ratio for 0013.HK, comparing it with other companies in the Drug Manufacturers - Specialty & Generic industry. Currently, 0013.HK has a P/E ratio of 72.6. This P/E ratio is significantly higher than those of industry peers. This could indicate that the stock is overvalued or that investors expect strong future growth.

PEG Ratio

The chart shows the Price/Earnings to Growth (PEG) ratio for 0013.HK compared to other companies in the Drug Manufacturers - Specialty & Generic industry. 0013.HK currently has a PEG ratio of 0.0. This PEG ratio is low compared to industry peers, which could indicate the stock is undervalued relative to its expected growth.

PS Ratio

This chart shows the Price-to-Sales (P/S) ratio for 0013.HK relative to other companies in the Drug Manufacturers - Specialty & Generic industry. Currently, 0013.HK has a P/S ratio of 31.5. This P/S ratio is high relative to other companies in the industry. It could mean the stock is overvalued, or that investors expect strong future growth and profitability.

PB Ratio

The chart illustrates the Price-to-Book (P/B) ratio for 0013.HK in comparison with other companies in the Drug Manufacturers - Specialty & Generic industry. Currently, 0013.HK has a P/B value of 3.3. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items